160 related articles for article (PubMed ID: 10863150)
1. The management of adult aggressive non-Hodgkin's lymphomas.
Couderc B; Dujols JP; Mokhtari F; Norkowski JL; Slawinski JC; Schlaifer D
Crit Rev Oncol Hematol; 2000 Jul; 35(1):33-48. PubMed ID: 10863150
[TBL] [Abstract][Full Text] [Related]
2. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
3. The present status of therapy for patients with aggressive non-Hodgkin's lymphoma.
Vose JM; Armitage JO
Ann Oncol; 1991 Feb; 2 Suppl 2():171-6. PubMed ID: 2049315
[TBL] [Abstract][Full Text] [Related]
4. Therapy of non-Hodgkin's lymphoma.
Coffey J; Hodgson DC; Gospodarowicz MK
Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S28-36. PubMed ID: 12692688
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous non-Hodgkin's lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement.
Visco C; Medeiros LJ; Jones D; Smith T; Rodriguez MA; McLaughlin P; Romaguera J; Cabanillas F; Sarris AH
Ann Oncol; 2002 Aug; 13(8):1290-9. PubMed ID: 12181254
[TBL] [Abstract][Full Text] [Related]
6. A systematic overview of chemotherapy effects in aggressive non-Hodgkin's lymphoma.
Kimby E; Brandt L; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):198-212. PubMed ID: 11441932
[TBL] [Abstract][Full Text] [Related]
7. Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?
Josting A; Reiser M; Rueffer U; Salzberger B; Diehl V; Engert A
J Clin Oncol; 2000 Jan; 18(2):332-9. PubMed ID: 10637247
[TBL] [Abstract][Full Text] [Related]
8. Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group.
Oguchi M; Ikeda H; Isobe K; Hirota S; Hasegawa M; Nakamura K; Sasai K; Hayabuchi N
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):161-8. PubMed ID: 10924986
[TBL] [Abstract][Full Text] [Related]
9. International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury.
Shipp MA; Abeloff MD; Antman KH; Carroll G; Hagenbeek A; Loeffler M; Montserrat E; Radford JA; Salles G; Schmitz N; Symann M; Armitage JO; Coiffier B; Philip T
Ann Oncol; 1999 Jan; 10(1):13-9. PubMed ID: 10076716
[No Abstract] [Full Text] [Related]
10. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
11. Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Zinzani PL; Martelli M; Poletti V; Vitolo U; Gobbi PG; Chisesi T; Barosi G; Ferreri AJ; Marchetti M; Pimpinelli N; Tura S; ; ;
Haematologica; 2008 Sep; 93(9):1364-71. PubMed ID: 18603558
[TBL] [Abstract][Full Text] [Related]
12. Etoposide in the treatment of non-Hodgkin's lymphomas.
Young RC
Semin Oncol; 1992 Dec; 19(6 Suppl 13):19-25. PubMed ID: 1492224
[TBL] [Abstract][Full Text] [Related]
13. VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.
Santini G; Coser P; Congiu AM; Salvagno L; De Souza C; Sertoli MR; Olivieri A; Chisesi T; Rubagotti A; Truini M; Contu A; Porcellini A; Zambaldi G; Nati S; Marino G; Rizzoli V
Haematologica; 2000 Feb; 85(2):160-6. PubMed ID: 10681723
[TBL] [Abstract][Full Text] [Related]
14. Non-Hodgkin's lymphoma.
Smith MR
Curr Probl Cancer; 1996; 20(1):6-77. PubMed ID: 8919170
[TBL] [Abstract][Full Text] [Related]
15. [High-grade non-Hodgkin lymphoma: diagnosis and therapy].
Trümper L; Pfreundschuh M
Ther Umsch; 1996 Feb; 53(2):133-9. PubMed ID: 8629263
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of mobilization kinetics of circulating CD34+ cells between biweekly CHOP and dose-escalated CHOP with the prophylactic use of lenograstim (glycosylated rHuG-CSF) in aggressive non-Hodgkin's lymphoma. The lenograstim/Lymphoma Study Group.
Itoh K; Ohtsu T; Sasaki Y; Ogura M; Morishima Y; Kasai M; Chou T; Yoshida K; Ohno T; Mizorogi F; Uike N; Sai T; Taniwaki M; Ikeda S; Tobinai K
Leuk Lymphoma; 2000 Aug; 38(5-6):521-32. PubMed ID: 10953973
[TBL] [Abstract][Full Text] [Related]
17. The non-Hodgkin's lymphomas: pathology, staging, treatment.
Hoppe RT
Curr Probl Cancer; 1987; 11(6):363-447. PubMed ID: 3125008
[TBL] [Abstract][Full Text] [Related]
18. [Recent progress in the treatment of malignant lymphoma].
Ogura M
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1213-35. PubMed ID: 11579632
[TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin's lymphomas in children. II. Treatment.
White L; Siegel SE; Quah TC
Crit Rev Oncol Hematol; 1992 Jul; 13(1):73-89. PubMed ID: 1449620
[TBL] [Abstract][Full Text] [Related]
20. Treatment results of tonsillar lymphoma: a 10-year experience.
Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
